SD

Sampat D Jain

Active Director Designated Partner DIN 09228574
DIN 09228574 First appointment Jul 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sampat D Jain

Data last updated:

Sampat D Jain is a Designated Partner at Qualicare Pharmaceutical Llp (since 2021). The company operates in Pharma.

DIN 09228574
Primary Designation Designated Partner
Industry Pharma
First Appointment 06 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner06 Jul 20212021Active

Board colleagues of Sampat D Jain

NameDINCompanyDesignation
Ashok Vithal Giri09228522Qualicare Pharmaceutical LlpDesignated Partner
Mohan Govindrao Kekatpure08188184Qualicare Pharmaceutical LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Qualicare Pharmaceutical Llp
Premium access

Shareholding and investment profile for Sampat D Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sampat D Jain

Sampat D Jain currently holds 1 directorship: Qualicare Pharmaceutical Llp (Designated Partner, since 06 Jul 2021).

Sampat D Jain was first appointed on 06 Jul 2021 as Designated Partner at Qualicare Pharmaceutical Llp.

The current boards of Sampat D Jain's companies include Ashok Vithal Giri (Qualicare Pharmaceutical Llp), Mohan Govindrao Kekatpure (Qualicare Pharmaceutical Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available